APA (7th ed.) Citation

Bang, Y., Kim, Y., Yang, H., Chung, H. C., Park, Y., Lee, K. H., . . . Noh, S. H. (2012). Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): A phase 3 open-label, random ised controlled trial. Lancet, 379(9813), 315. https://doi.org/10.1016/S0140-6736(11)61873-4

Chicago Style (17th ed.) Citation

Bang, Yung-Jue, et al. "Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer After D2 Gastrectomy (CLASSIC): A Phase 3 Open-label, Random Ised Controlled Trial." Lancet 379, no. 9813 (2012): 315. https://doi.org/10.1016/S0140-6736(11)61873-4.

MLA (9th ed.) Citation

Bang, Yung-Jue, et al. "Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer After D2 Gastrectomy (CLASSIC): A Phase 3 Open-label, Random Ised Controlled Trial." Lancet, vol. 379, no. 9813, 2012, p. 315, https://doi.org/10.1016/S0140-6736(11)61873-4.